Altman presented his version of the neurointerface development

Altman presented his version of the neurointerface development

Altman presented his version of a neural interface Sam Altman presented Merge Labs, a startup that raised $252 million to develop a non-invasive brain-computer interface. Unlike solutions such as Neuralink, the project uses ultrasound and molecular agents to read neural signals through natural barriers. Investors include Bain Capital and Valve co-founder Gabe Newell. OpenAI believes that such interfaces will form the basis for a new way of interacting with AI. The scientific foundation was laid in the Forest Neurotech laboratory. The team includes leading scientists in the field of neurotechnology and executives from Tools for Humanity. It may take decades to create a commercial product, but investor interest reflects the high potential of the neurointerface market. Merge Labs will now focus on fundamental research.